VWWMG
WST icon

Vermillion & White Wealth Management Group’s West Pharmaceutical WST Stock Holding History

Vermillion & White Wealth Management Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-144
Closed -$39.6K – 542
2025
Q4 		$39.6K Hold
144
– – 0.02% 173
2025
Q3 		$37.8K Hold
144
– – 0.02% 180
2025
Q2 		$31.5K Buy
144
+95
+194% +$20.3K 0.02% 187
2025
Q1 		$11K Buy
+49
New +$13.5K 0.01% 272

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vermillion & White Wealth Management Group's WST Position: Q1 2026 in Review

Vermillion & White Wealth Management Group sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 144 shares — an estimated $39.6K sold.

Vermillion & White Wealth Management Group first reported a position in WST in Q1 2025 and held it in 4 quarters. The position peaked at $39.6K in Q4 2025. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Vermillion & White Wealth Management Group reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Vermillion & White Wealth Management Group sold 144 West Pharmaceutical shares in Q1 2026, an estimated $39.6K.
  • Vermillion & White Wealth Management Group first reported a position in West Pharmaceutical in Q1 2025 and held it in 4 quarters.
  • Vermillion & White Wealth Management Group's West Pharmaceutical position peaked at $39.6K in Q4 2025.
  • 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Vermillion & White Wealth Management Group's 13F filing for Q1 2026, filed 14 May 2026.